ARIPRA aripiprazole 15mg tablet blister pack

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

aripiprazole, Quantity: 15 mg

Inapatikana kutoka:

Medis Pharma Pty Ltd

INN (Jina la Kimataifa):

aripiprazole

Dawa fomu:

Tablet, uncoated

Tungo:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; hyprolose; maize starch; magnesium stearate

Njia ya uendeshaji:

Oral

Vitengo katika mfuko:

30

Dawa ya aina:

(S4) Prescription Only Medicine

Matibabu dalili:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.

Bidhaa muhtasari:

Visual Identification: 7mm, round, biconvex, white uncoated tablets with 15 debossed on one side and ZL on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Idhini hali ya:

Licence status A

Idhini ya tarehe:

2014-10-29